O Ministério Público Federal entrou com uma ação autorizativa para a importação de canabidiol a 16 pacientes na Paraíba. A Agência Nacional de Vigilância Sanitária proíbe o composto químico presente na maconha à pacientes. O medicamento serve para auxilia no tratamento de crises convulsivas. Em casos únicos em Pernambuco e no Distrito Federal a Justiça autorizou o uso da substância para portadores de síndromes epiléticas.
© Saúde & Direitos Sociais - Todos os Direitos Reservados
| Cookie | Duração | Descrição |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
